SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001214659-22-000293
Filing Date
2022-01-05
Accepted
2022-01-05 06:04:01
Documents
12
Period of Report
2022-01-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 c12272108k.htm   iXBRL 8-K 31902
  Complete submission text file 0001214659-22-000293.txt   204710

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hgen-20220103.xsd EX-101.SCH 2717
3 XBRL LABEL FILE hgen-20220103_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE hgen-20220103_pre.xml EX-101.PRE 22343
6 EXTRACTED XBRL INSTANCE DOCUMENT c12272108k_htm.xml XML 3574
Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35798 | Film No.: 22509324
SIC: 2834 Pharmaceutical Preparations